Abstract CT503: A Phase I/Ib Study of the Safety and Preliminary Efficacy of NZV930 Alone and in Combination with Spartalizumab And/or Taminadenant in Patients (pts) with Advanced Malignancies
Cancer research(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要